Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
BMC Public Health|June 1, 2019
Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online surveyOdette Wegwarth, Nora Pashayan, Martin Widschwendter, et al.
Annals of the New York Academy of Sciences|July 15, 2004
Prognostic DNA methylation marker in serum of cancer patientsHannes M Müller, Heidi Fiegl, Andreas Widschwendter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 10, 2026
Cost-minimisation analysis of the WID-qEC epigenetic biomarker compared to transvaginal ultrasound for triaging abnormal uterine bleedingTristan M Snowsill, Sara Sleigh, James Barrett, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Pregnancy as a tissue expander in the correction of a scar deformityBarbara Del Frari, Petra Pülzl, Thomas Schoeller, et al.
Epigenomics|November 30, 2011
Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancersAllison Jones, Matthias Lechner, Evangelia-Ourania Fourkala, et al.
International Journal of Cancer|July 7, 2018
Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathwaysTheresa Austria, Christine Marion, Vanessa Yu, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
Prediction models for endometrial cancer for the general population or symptomatic women: A systematic reviewMaaike Alblas, Kimberley B Velt, Nora Pashayan, et al.
Genome Medicine|August 27, 2016
The multi-omic landscape of transcription factor inactivation in cancerAndrew E Teschendorff, Shijie C Zheng, Andy Feber, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Fooled by the film: delayed diagnosis of incarcerated small-bowel hernia after laparoscopic surgery for endometrial cancerAdam N Rosenthal, Gary Heron, Martin Widschwendter, et al.
British Journal of Cancer|February 3, 2017
Comparison of two protocols for the management of asymptomatic postmenopausal women with adnexal tumours - a randomised controlled trial of RMI/RCOG vs Simple RulesNatalie Nunes, Gareth Ambler, Xulin Foo, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
BMC Public Health|June 1, 2019
Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online surveyOdette Wegwarth, Nora Pashayan, Martin Widschwendter, et al.
Annals of the New York Academy of Sciences|July 15, 2004
Prognostic DNA methylation marker in serum of cancer patientsHannes M Müller, Heidi Fiegl, Andreas Widschwendter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 10, 2026
Cost-minimisation analysis of the WID-qEC epigenetic biomarker compared to transvaginal ultrasound for triaging abnormal uterine bleedingTristan M Snowsill, Sara Sleigh, James Barrett, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Pregnancy as a tissue expander in the correction of a scar deformityBarbara Del Frari, Petra Pülzl, Thomas Schoeller, et al.
Epigenomics|November 30, 2011
Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancersAllison Jones, Matthias Lechner, Evangelia-Ourania Fourkala, et al.
International Journal of Cancer|July 7, 2018
Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathwaysTheresa Austria, Christine Marion, Vanessa Yu, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
Prediction models for endometrial cancer for the general population or symptomatic women: A systematic reviewMaaike Alblas, Kimberley B Velt, Nora Pashayan, et al.
Genome Medicine|August 27, 2016
The multi-omic landscape of transcription factor inactivation in cancerAndrew E Teschendorff, Shijie C Zheng, Andy Feber, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Fooled by the film: delayed diagnosis of incarcerated small-bowel hernia after laparoscopic surgery for endometrial cancerAdam N Rosenthal, Gary Heron, Martin Widschwendter, et al.
British Journal of Cancer|February 3, 2017
Comparison of two protocols for the management of asymptomatic postmenopausal women with adnexal tumours - a randomised controlled trial of RMI/RCOG vs Simple RulesNatalie Nunes, Gareth Ambler, Xulin Foo, et al.
Pageof 18